Literature DB >> 8204501

Immune modulating therapies for idiopathic inflammatory bowel diseases.

D S Levine1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8204501     DOI： 10.1016/s1054-3589(08)60432-9

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  3 in total

1.  Evaluation of oral beclomethasone dipropionate for prevention of acute graft-versus-host disease.

Authors:  Paul J Martin; Terry Furlong; Scott D Rowley; Steven A Pergam; Michele Lloid; Mark M Schubert; Kevin J Horgan; Barry E Storer
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-09       Impact factor: 5.742

2.  Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials.

Authors:  J W Chien; M Sakai; T A Gooley; H G Schoch; G B McDonald
Journal:  Bone Marrow Transplant       Date:  2009-06-29       Impact factor: 5.483

3.  Citrus Huanglongbing is a pathogen-triggered immune disease that can be mitigated with antioxidants and gibberellin.

Authors:  Wenxiu Ma; Zhiqian Pang; Xiaoen Huang; Jin Xu; Sheo Shankar Pandey; Jinyun Li; Diann S Achor; Fernanda N C Vasconcelos; Connor Hendrich; Yixiao Huang; Wenting Wang; Donghwan Lee; Daniel Stanton; Nian Wang
Journal:  Nat Commun       Date:  2022-01-26       Impact factor: 17.694
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.